Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeng Yan

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Endocrinology|September 17, 2005
A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese ratsHansen M Hsiung, Jeanne Hertel, Xing-Yue Zhang, et al.
Oncology Letters|June 18, 2016
Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)/promyelocytic leukemia/retinoic acid receptor alphaN A Gao, Wen-Zheng Yu, Xue-Xia Wang, et al.
Chemotherapy|March 29, 2023
A 7-Day Decitabine-Included Conditioning Regimen Accelerated Donor Hematopoietic Engraftment while Reduced the Occurrence of Mucositis without Interfering with PrognosisYuan Yuan Shi, Long Su, Zeng Yan Liu, et al.
Molecular Cancer Therapeutics|December 16, 2014
Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic modelsSheng-Bin Peng, Xiaoyi Zhang, Donald Paul, et al.
Current Topics in Medicinal Chemistry|June 23, 2007
Structure-activity relationships of beta-MSH derived melanocortin-4 receptor peptide agonistsLiang Zeng Yan, Hansen M Hsiung, Mark L Heiman, et al.
Oncogenesis|June 24, 2022
Correction: FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathwaysYan-Feng Huang, Wen-Bo Niu, Rong Hu, et al.
Oncogenesis|October 3, 2018
FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathwaysYan-Feng Huang, Wen-Bo Niu, Rong Hu, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|March 18, 2011
Discovery of potent, cyclic calcitonin gene-related peptide receptor antagonistsLiang Zeng Yan, Kirk W Johnson, Emily Rothstein, et al.
Journal of Medicinal Chemistry|December 19, 2008
Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacyYing-Hong Li, Peng Yang, Wei-Jia Kong, et al.
British Journal of Pharmacology|October 2, 2018
Hispaglabridin B, a constituent of liquorice identified by a bioinformatics and machine learning approach, relieves protein-energy wasting by inhibiting forkhead box O1Zeng-Yan Huang, Ling-Jun Wang, Jia-Jia Wang, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Endocrinology|September 17, 2005
A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese ratsHansen M Hsiung, Jeanne Hertel, Xing-Yue Zhang, et al.
Oncology Letters|June 18, 2016
Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)/promyelocytic leukemia/retinoic acid receptor alphaN A Gao, Wen-Zheng Yu, Xue-Xia Wang, et al.
Chemotherapy|March 29, 2023
A 7-Day Decitabine-Included Conditioning Regimen Accelerated Donor Hematopoietic Engraftment while Reduced the Occurrence of Mucositis without Interfering with PrognosisYuan Yuan Shi, Long Su, Zeng Yan Liu, et al.
Molecular Cancer Therapeutics|December 16, 2014
Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic modelsSheng-Bin Peng, Xiaoyi Zhang, Donald Paul, et al.
Current Topics in Medicinal Chemistry|June 23, 2007
Structure-activity relationships of beta-MSH derived melanocortin-4 receptor peptide agonistsLiang Zeng Yan, Hansen M Hsiung, Mark L Heiman, et al.
Oncogenesis|June 24, 2022
Correction: FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathwaysYan-Feng Huang, Wen-Bo Niu, Rong Hu, et al.
Oncogenesis|October 3, 2018
FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathwaysYan-Feng Huang, Wen-Bo Niu, Rong Hu, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|March 18, 2011
Discovery of potent, cyclic calcitonin gene-related peptide receptor antagonistsLiang Zeng Yan, Kirk W Johnson, Emily Rothstein, et al.
Journal of Medicinal Chemistry|December 19, 2008
Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacyYing-Hong Li, Peng Yang, Wei-Jia Kong, et al.
British Journal of Pharmacology|October 2, 2018
Hispaglabridin B, a constituent of liquorice identified by a bioinformatics and machine learning approach, relieves protein-energy wasting by inhibiting forkhead box O1Zeng-Yan Huang, Ling-Jun Wang, Jia-Jia Wang, et al.
Pageof 10